Assured Investment Management’s Charles River Laboratories CRL Stock Holding History

Assured Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-112	Closed	-$12K	–	1190
2018 Q1	$12K	Buy	+112	New	+$12.1K	﹤0.01%	1114
2017 Q4	–	Sell	-12,863	Closed	-$1.39M	–	542
2017 Q3	$1.39M	Buy	+12,863	New	+$1.32M	0.03%	383
2016 Q3	–	Sell	-8,549	Closed	-$705K	–	614
2016 Q2	$705K	Buy	+8,549	New	+$704K	0.02%	342
2016 Q1	–	Sell	-6,533	Closed	-$525K	–	630
2015 Q4	$525K	Sell	6,533 -7,519	-54%	-$542K	0.01%	289
2015 Q3	$893K	Buy	14,052 +13,549	+2,694%	+$973K	0.02%	240
2015 Q2	$35K	Buy	+503	New	+$37.2K	﹤0.01%	613

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Assured Investment Management's CRL Position: Q2 2018 in Review

Assured Investment Management sold out of Charles River Laboratories (CRL) in Q2 2018, closing a stake of 112 shares — an estimated $12K sold.

Assured Investment Management first reported a position in CRL in Q2 2015 and held it in 6 quarters. The position peaked at $1.39M in Q3 2017. 348 funds tracked by Wall St. Rank hold CRL as of Q2 2018.

Assured Investment Management reported no remaining Charles River Laboratories position as of Q2 2018 after selling out during the quarter.
Assured Investment Management sold 112 Charles River Laboratories shares in Q2 2018, an estimated $12K.
Assured Investment Management first reported a position in Charles River Laboratories in Q2 2015 and held it in 6 quarters.
Assured Investment Management's Charles River Laboratories position peaked at $1.39M in Q3 2017.
348 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2018.

Based on Assured Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.